United Kingdom· GB-APID-40253611000001105
Ponvory 10mg tablets
A ponesimod product containing ponesimod, registered in United Kingdom by Juvise Pharmaceuticals. The same ATC class is registered in 11 of our 19 countries.
Checked against NHS dm+d (United Kingdom) on
Informational only — not a medical device.
Where it is registered
Ponesimod is registered in 11 of 19 countries.
Countries holding a registration under ATC L04AE04 (ponesimod), each read from that country’s own register.
- This record: United Kingdom, from NHS dm+d (United Kingdom)
- 7 of them publish a price we can compare per daily dose
Ponesimod · ATC L04AE04
11 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Italyprice
- Netherlands
- Norwayprice
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of ponesimod costs, country by country.
Normalised to the WHO defined daily dose (20 mg), so markets compare like for like.
- 2 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Ponesimod · price per daily dose (20 mg)
USD · FX 28 Sept 2026
- IT Italy$69.77
- CH Switzerland$69.06
The record
At a glance
NHS dm+d (United Kingdom)- Active substance
- Ponesimod
- Manufacturer
- Juvise Pharmaceuticals
- Country
- United Kingdom (GB)
- ATC code
- L04AE04
- ATC class
- Ponesimod
- Defined daily dose
- 20 mg, O
- Reimbursed
- Not published by this register
- Source register
- NHS dm+d (United Kingdom)
- Last checked
- September 13, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Ponesimod in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- NorwayPonvoryLABORATOIRES JUVISE PHARMACEUTICALS
- SwitzerlandPonvory 10 mg, FilmtablettenMedius AG
- CzechiaPONVORYLaboratoires Juvisé Pharmaceuticals, Villeurbanne
- IrelandPonvory 2 mg+3 mg+4 mg+5 mg+6 mg+7 mg+8 mg+9 mg+10 mg film-coated tabletsLaboratoires Juvise Pharmaceuticals
- IcelandPonvoryLABORATOIRES JUVISE PHARMACEUTICALS
- ItalyPONVORY*14 cpr rivestite confezione di inizio trattamentoLAB.JUVISE' PHARMACEUTICALS
- NetherlandsPonvory 2 mg + 3 mg + 4 mg + 5 mg + 6 mg + 7 mg + 8 mg + 9 mg + 10 mg filmomhulde tablettenLaboratoires Juvise Pharmaceuticals
- United StatesPONVORYVanda Pharmaceuticals Inc.
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Ponvory
- Liechtenstein · Ponvory
- Norway · Ponvory
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/878daec0-9418-4d33-bbb6-aa5688f80e6c GET /v1/drugs/878daec0-9418-4d33-bbb6-aa5688f80e6c?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"apid": "40253611000001105",
"desc": "Ponvory 10mg tablets (Juvise Pharmaceuticals)",
"form": "Oral tablet",
"vpid": "40272211000001104",
"source": "dmd",
"vtm_id": "1179255001",
"strength": "10 mg",
"substance": "Ponesimod",
"ingredient": "Ponesimod",
"supplier_code": "45108211000001100"
}See everything about ponesimod.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.